title: Unusual spectral shifts of imipramine and carbamazepine drugs.
abstract: The absorption and fluorescence spectra of imipramine and carbamazepine have been recorded in solvents of different polarity and β-cyclodextrin (β-CD). The inclusion complexes for both drugs are investigated by UV-visible, fluorimetry and DFT. Solvents study shows isotropic polarizability structure is present in imipramine while the amide group inhibits the above structure in carbamazepine. The band width half a maximum of carbamazepine decreased in polar solvents suggest that different species present in non-polar solvents and among that one of this species is affected in protic solvents. Both drugs form two different 1:2 inclusion complexes with β-CD. The structured longer wavelength emission in β-CD solution suggests viscosity plays major roles in the inclusion complex. This study also confirms van der Waals forces and hydrophobic interactions are the driving forces in imipramine and hydrogen bonding interactions play major roles in carbamazepine.
authors.affiliation: Department of Chemistry, Annamalai University, Annamalai nagar, 608 002, Tamilnadu, India.
authors.forename: A Antony Muthu
authors.initials: AA
authors.lastname: Prabhu
authors.forename: G
authors.initials: G
authors.lastname: Venkatesh
authors.forename: N
authors.initials: N
authors.lastname: Rajendiran
mesh_terms: D002220:Carbamazepine / Q000737:chemistry*; D006860:Hydrogen Bonding; D007099:Imipramine / Q000737:chemistry*; D008958:Models, Molecular; D015394:Molecular Structure; D012015:Reference Standards; D012997:Solvents / Q000737:chemistry; D013050:Spectrometry, Fluorescence / Q000592:standards; D014783:Viscosity; D047392:beta-Cyclodextrins / Q000737:chemistry
chemical_list: D012997:Solvents; D047392:beta-Cyclodextrins; D002220:Carbamazepine; C031215:betadex; D007099:Imipramine
references.citation: J Am Chem Soc. 1976 May 12;98(10):3001-7
references.pmid: 1262629
references.citation: J Fluoresc. 2010 Jan;20(1):43-54
references.pmid: 19669393
references.citation: J Pharm Sci. 1982 Feb;71(2):217-22
references.pmid: 7062249
references.citation: Analyst. 2000 Aug;125(8):1465-70
references.pmid: 11002929
references.citation: Drugs. 2002;62(17):2471-79; discussion 2480-1
references.pmid: 12421104
references.citation: Spectrochim Acta A Mol Biomol Spectrosc. 2003 Oct;59(12):2759-66
references.pmid: 14499836
references.citation: Spectrochim Acta A Mol Biomol Spectrosc. 2009 Oct 1;74(2):484-97
references.pmid: 19628426
references.citation: Biomed Chromatogr. 2000 Jun;14(4):219-26
references.pmid: 10861732
references.citation: Chem Rev. 1998 Jul 30;98(5):2045-2076
references.pmid: 11848959
references.citation: Spectrochim Acta A Mol Biomol Spectrosc. 2003 Oct;59(12):2697-703
references.pmid: 14499829
references.citation: Analyst. 1999 Apr;124(4):587-91
references.pmid: 10605882
references.citation: Analyst. 1998 Jul;123(7):1587-91
references.pmid: 9830171
references.citation: Spectrochim Acta A Mol Biomol Spectrosc. 2003 Mar 15;59(5):909-16
references.pmid: 12633708
references.citation: J Photochem Photobiol B. 1998 May 15;43(2):112-20
references.pmid: 9679313